Baseline magnetic resonance imaging parameters and stroke outcome in patients treated by intravenous tissue plasminogen activator

Stroke

Volumn 34, Issue 2, 2003, Pages 458-463

  Nighoghossian, N ^a,b   Hermier, M ^a,b   Adeleine, P ^a   Derex, L ^a,b   Dugor, J F ^a   Philippeau, F ^a   Ylmaz, H ^a   Honnorat, J ^a   Dardel, P ^a   Berthezene Y ^b   Froment, J C ^a,b   Trouillas, P ^a  

^a HÔPITAL NEUROLOGIQUE   (France)

^b CNRS   (France)

Author keywords

Magnetic resonance imaging, diffusion weighted; Magnetic resonance imaging, perfusion weighted; Stroke outcome; Tissue plasminogen activator

Indexed keywords

TISSUE PLASMINOGEN ACTIVATOR;

ADULT; AGED; ARTICLE; BLOOD CLOT LYSIS; CEREBROVASCULAR ACCIDENT; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEATH; DIFFUSION WEIGHTED IMAGING; DISABILITY; FEMALE; HUMAN; INDEPENDENCE; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; MULTIPLE REGRESSION; NATIONAL INSTITUTES OF HEALTH STROKE SCALE; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOMES RESEARCH; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANKIN SCALE; RATING SCALE; RECANALIZATION; SCORING SYSTEM; SYMPTOM; TIME;

ACUTE DISEASE; ADULT; AGED; AGED, 80 AND OVER; CEREBROVASCULAR ACCIDENT; DIFFUSION; DISEASE PROGRESSION; ECHO-PLANAR IMAGING; FEMALE; HUMANS; INJECTIONS, INTRAVENOUS; LINEAR MODELS; MAGNETIC RESONANCE ANGIOGRAPHY; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RECOMBINANT PROTEINS; SEVERITY OF ILLNESS INDEX; TISSUE PLASMINOGEN ACTIVATOR; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 0037319336     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.0000053850.64877.AF     Document Type: Article

References (25)

1. NINDS rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med. 1995;333:1581-1587.
2. Furlan A, Higashida R, Wechsler L, Gent M, Rowley H, Kase C, Pessin M, Ahuja A, Callahan F, Clark WM, Silver F, Rivera F. Intra-arterial prourokinase for acute ischemic stroke: the PROACT II Study: a randomized controlled trial. JAMA. 1999;282:20003-20011.
3. Marks MP, Tong DC, Beaulieu C, Albers GW, de Crespigny A, Moseley ME. Evaluation of early reperfusion and iv tPA therapy using diffusion and perfusion weighted MRI. Neurology. 1999;52:1792-1798.
4. Jansen O, Schellinger P, Fiebach J, Hacke W, Sartor K. Early recanalisation in acute ischemic stroke saves tissue at risk defined by MRI. Lancet. 1999;353:2036-2037.
5. Schellinger PD, Fiebach JB, Jansen O, Ringleb PA, Mohr A, Steiner T, Heiland S, Schwab S, Pohlers O, Ryssel H, Orakcioglu B, Sartor K, Hacke W. Stroke magnetic resonance imaging within 6 hours after onset of hyperacute cerebral ischemia. Ann Neurol. 2001;49:460-469.
6. Kidwell CS, Saver J, Mattiello J, Starkman S, Vinuela F, Duckwiler G, Gobin P, Jahan R, Vespa P, Kalafut M, Alger JR. Thrombolytic reversal of acute human cerebral ischemic injury shown by diffusion/perfusion magnetic resonance imaging. Ann Neurol. 2000;47:462-469.
7. Parsons MW, Barber PA, Chalk J, Darby DG, Rose S, Desmond PM, Gerraty RP, Tress BM, Wright PM, Donnan GA, Davis SM. Diffusion and perfusion MRI-weighted MRI response to thrombolysis in stroke. Ann Neurol. 2002;51:28-37.
8. Barber PA, Darby DG, Desmond PM, Yang Q, Gerraty RP, Jolley D, Donnan GA, Tress BM, Davis SM. Prediction of stroke outcome with echoplanar perfusion and diffusion weighted MRI. Neurology. 1998;51: 418-426.
9. Adams HJ, Bendixen B, Kapelle L, Biller J, Love B, Gordon D, Marsh E. Classification of subtype of acute ischemic stroke: definition for use in a multicenter clinical trial: TOAST (Trial of Org 10172 in Acute stroke Treatment). Stroke. 1993;24:35-41.
10. st week: A longitudinal study. Radiology. 2000;217:886-894.
11. Trouillas P, Nighoghossian N, Derex L, Adeleine P, Honnorat J, Neuschwander PH, Riche G, Getenet JC, Li W, Froment JC, Turjman F, Malicier D, Fournier G, Gabry AL, Ledoux X, Berthèzene Y, French P, Dechavanne M. Thrombolysis in a series of 100 cases of acute carotid territory stroke with intravenous tissue plasminogen activator: determination of etiological, topographical, and radiological outcome factors. Stroke. 1998;29:2529-2540.
12. Warach S. Tissue viability thresholds in acute stroke: the 4-factor model. Stroke. 2001;32:2460-2461.
13. Tong DC, Yenari MA, Albers GW, O'Brien M, Marks MP, Moseley ME. Correlation of perfusion and diffusion-weighted MRI with NIHSS score in acute (<6.5 hour) ischemic stroke. Neurology. 1998;50:864-870.
14. Barber PA, Davis SM, Darby DG, Desmond PM, Gerraty RP, Yang Q, Jolley D, Donnan GA, Tress BM. Absent middle cerebral artery flow predicts the presence and evolution of the ischemic penumbra. Neurology. 1999;52:1125-1132.
15. Warach S, Dashe JF, Edelman RR. Clinical outcome in ischemic stroke predicted by early diffusion-weighted and perfusion magnetic resonance imaging: a preliminary analysis. J Cereb Blood Flow Metab. 1996;16: 53-59.
16. Sorensen AG, Buonanno FS, Gonzalez RG, Schwamm LH, Lev MH, Huang-Hellinger FR, Reese TG, Weisskoff RM, Davis TL, Suwanwela N, et al. Hyperacute stroke: evaluation with combined multisection diffusion weighted and hemodynamically weighted echo-planar MR imaging. Radiology. 1996;199:391-401.
17. Sorensen AG, Copen WA, Østergaard L, Buonanno FS, Gonzales RG, Rordorf G, Rosen BR, Schwamm LH, Weisskoff RM, Koroshetz WJ. Hyperacute stroke: simultaneous measurement of relative cerebral blood volume, relative cerebral blood flow, and mean tissue transit time. Radiology. 1999;210:519-527.
18. Neumann-Hafelin T, Wittzack HJ, Wenserski, F, Siebler M, Seitz RJ, Mödder U, Freund HJ. Diffusion- and perfusion weighted MRI: the DWI/PWI mismatch region in acute stroke. Stroke. 1999;30:1591-1597.
19. Schlaug G, Benfield A, Baird AE, Siegert B, Lövblad KO, Parker RA, Edelman RR, Warach S. The ischemic penumbra operationally defined by diffusion and perfusion MRI. Neurology. 1999;53:1528-1537.
20. Parsons MW, Yang Q, Barber PA, Darby DG, Desmond PM, Gerraty RP, Tress BM, Davis SM. Perfusion magnetic resonance imaging maps in hyperacute stroke: relative cerebral blood flow most accurately identify tissue destined to infarct. Stroke. 2001;32:1581-1587.
21. Thijs VN, Maarten G M, Beaulieu C, Marks MP, Moseley ME, Albers GW. Is early ischemic lesion volume on diffusion-weighted imaging an independent predictor of stroke outcome? a multivariable analysis. Stroke. 2000;31:2597-2602.
22. Beaulieu C, de Crespigny A, Tong DC, Moseley ME, Albers GW, Marks MP. Longitudinal magnetic imaging study of perfusion and diffusion in stroke: evolution of lesion volume and correlation with clinical outcome. Ann Neurol. 1999;46:568-578.
23. Thijs VN, Adami A, Neumann-Hafelin T, Moseley ME, Marks MP, Albers GW. Relationship between severity of MR perfusion deficit and DWI lesion evolution. Neurology. 2001;57:1205-1211.
24. Fiehler J, Knab R, Reichenbach JR, Fitzek C, Weiller C, Röther J. Apparent diffusion coefficient decreases and magnetic resonance imaging perfusion parameters are associated in ischemic tissue of acute stroke patients. J Cereb Blood Flow Metab. 2001;21:577-584.
25. Molina CA, Montaner J, Abilleira S, Arenillas JF, Ribo M, Huertas R, Romero F, Alvarez-Sabin J. Time course of tissue plasminogen activator-induced recanalization in acute cardioembolic stroke. Stroke. 2001;32:2821-2827.